Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion type Assertion NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_head.
- NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion description "[These studies demonstrated that: (a) alpha 1-antitrypsin is the major antielastase of the normal human lower respiratory tract; (b) alpha 2-macroglobulin, a large serum antielastase, and the bronchial mucous inhibitor, an antielastase of the central airways, do not contribute to the antielastase protection of the human alveolar structures; (c) individuals with PiZ alpha 1-antitrypsin deficiency have little or no alpha 1-antitrypsin in their lower respiratory tract and have no alternative antiprotease protection against neutrophil elastase; and (d) the lack of antiprotease protection of the lower respiratory tract of PiZ individuals is a chronic process, suggesting their vulnerability to neutrophil elastase is always present.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_provenance.
- NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion evidence source_evidence_literature NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_provenance.
- NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion SIO_000772 6169740 NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_provenance.
- NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion wasDerivedFrom befree-20140225 NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_provenance.
- NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_assertion wasGeneratedBy ECO_0000203 NP773556.RAsnY7bO9kiefn-F4GG3rDUGFaQUkcxUlZ-xWCWhdZO8U130_provenance.